| Literature DB >> 25765284 |
Yuxiao Wang1, Tienhuei G Ho1, Eugen Franz2, Jennifer S Hermann2, F Donelson Smith3, Heidi Hehnly3, Jessica L Esseltine3, Laura E Hanold1, Mandi M Murph1, Daniela Bertinetti2, John D Scott3, Friedrich W Herberg2, Eileen J Kennedy1.
Abstract
A-Kinase Anchoring Proteins (AKAPs) coordinate complex signaling events by serving as spatiotemporal modulators of cAMP-dependent protein kinase activity in cells. Although AKAPs organize a plethora of diverse pathways, their cellular roles are often elusive due to the dynamic nature of these signaling complexes. AKAPs can interact with the type I or type II PKA holoenzymes by virtue of high-affinity interactions with the R-subunits. As a means to delineate AKAP-mediated PKA signaling in cells, we sought to develop isoform-selective disruptors of AKAP signaling. Here, we report the development of conformationally constrained peptides named RI-STapled Anchoring Disruptors (RI-STADs) that target the docking/dimerization domain of the type 1 regulatory subunit of PKA. These high-affinity peptides are isoform-selective for the RI isoforms, can outcompete binding by the classical AKAP disruptor Ht31, and can selectively displace RIα, but not RIIα, from binding the dual-specific AKAP149 complex. Importantly, these peptides are cell-permeable and disrupt Type I PKA-mediated phosphorylation events in the context of live cells. Hence, RI-STAD peptides are versatile cellular tools to selectively probe anchored type I PKA signaling events.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25765284 PMCID: PMC4475429 DOI: 10.1021/acschembio.5b00009
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 5.100